Common Fund Programs with Open Funding Opportunities
Expand All to search section using Ctrl+F |
Expand All
CARE for Health™
Somatic Cell Genome Editing (SCGE)
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) | March 22, 2024 | RFA-RM-24-007 | Betty Poon, Ph.D., poonb@mail.nih.gov | LOI Due Date: Application Receipt Date: |
High-Risk Research: NIH Director's Early Independence Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional) | 3/19/2024 | RFA-RM-24-005 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 | 9/6/2024 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-23-189 | Becky Miller earlyindependence@mail.nih.gov 301-594-9979 |
High-Risk Research: NIH Director's New Innovator Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional) | 3/19/2024 | RFA-RM-24-003 | Patricia (Trish) Labosky NewInnovatorAward@mail.nih.gov | 8/19/2024 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-23-189 | Patricia (Trish) Labosky NewInnovatorAward@mail.nih.gov |
High-Risk Research: NIH Director's Pioneer Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) | 3/21/2024 | RFA-RM-24-002 | Patricia (Trish) Labosky PioneerAwards@mail.nih.gov | 9/9/2024 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-23-189 | Patricia (Trish) Labosky PioneerAwards@mail.nih.gov |
High-Risk Research: NIH Director's Transformative Award Program
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Date |
|---|---|---|---|---|
| NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional) | 3/19/2024 | RFA-RM-24-004 | Patricia (Trish) Labosky Transformative_Awards@mail.nih.gov | 9/3/2024 |
| Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) | 11/16/2020 | PA-23-189 | Patricia (Trish) Labosky Transformative_Awards@mail.nih.gov |
Replication Initiative
| Title | NIH Guide | RFA Number | Common Fund Contact | Application Receipt Dates |
|---|---|---|---|---|
| Notice of Special Interest (NOSI): Administrative supplements to active Common Fund awards to support replication studies | 7/8/2024 | NOT-RM-24-009 | Sahana N. Kukke, PhD CF-Replication@od.nih.gov Michelle R.J. Hamlet, PhD CF-Replication@od.nih.gov | Batch 1: 8/12/2024 Batch 2: 9/30/2024 |
